Who makes Intraoperitoneal local anesthetic administration?

Intraoperitoneal local anesthetic administration is developed by Rawalpindi Medical College.

What development phase is Intraoperitoneal local anesthetic administration in?

Intraoperitoneal local anesthetic administration is FDA-approved (marketed).

Last reviewed 2026-05-14 · How we verify

Intraoperitoneal local anesthetic administration

Rawalpindi Medical College · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Intraoperitoneal local anesthetic administration
Sponsor	Rawalpindi Medical College
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pain Relief Following Laparoscopic Cholecystectomy While Comparing Intra Abdominal Versus Sub Cutaneous Local Anesthetic Administration (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Intraoperitoneal local anesthetic administration CI brief — competitive landscape report
Intraoperitoneal local anesthetic administration updates RSS · CI watch RSS
Rawalpindi Medical College portfolio CI